A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures with the T2 Alpha Tibia Nailing System
Brief description of study
The purpose of this study is to show the safety and performance of the T2 Alpha Tibia Nailing System. Participants who will have surgery for their tibia fracture and the surgeon will be using the T2 Alpha Tibia Nail device as part of the planned standard of care. This device is not an experimental medical device and is approved by the United States Food and Drug Administration (FDA).
Clinical Study Identifier: s18-00732
ClinicalTrials.gov Identifier: NCT04015167
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
